Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seprehvir in Malignant Pleural Mesothelioma
NCT01721018Phase 2Completed
- Sponsor
- Virttu Biologics Limited
- Start
- Oct 2012
- Primary completion
- Nov 2016
- Countries
- 1
01
Overview
A Phase 2 trial of HSV-1716 in malignant pleural mesothelioma (MPM), sponsored by Virttu Biologics Limited. Started Oct 2012; status: completed.
02
Drugs
HSV-1716
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT01721018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01721018.